We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Sues Teva Over ANDA For Generic Lotrel

Law360 (September 21, 2004, 12:00 AM EDT) -- Swiss pharmaceutical company Novartis AG has sued Israeli generics maker Teva Pharmaceutical Industries Ltd. to block a generic version of its hypertension drug Lotrel.

Novartis said it has filed a lawsuit against Teva in the U.S. District Court for the District of New Jersey for patent infringement of its high blood-pressure medication Lotrel. It filed the lawsuit in the on Sept. 16.

Teva claims its own product doesn't infringe Lotrel's patent and also says the patent is invalid, according to Novartis.

In August, an update to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.